VIVIDION THERAPEUTICS Trademark

Trademark Overview


On Thursday, November 14, 2024, a trademark application was filed for VIVIDION THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the VIVIDION THERAPEUTICS trademark a serial number of 98853803. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, November 14, 2024. This trademark is owned by Vividion Therapeutics, Inc.. The VIVIDION THERAPEUTICS trademark is filed in the Pharmaceutical Products, Education & Entertainment Services, and Computer & Software Services & Scientific Services categories with the following description:

Providing a website featuring blogs and non-downloadable publications in the nature of articles in the fields of cancer, immune disorders, pharmaceuticals, and proteomics; Providing a website featuring non-downloadable publications in the nature of articles in the fields of cancer, immune disorders, pharmaceuticals, and proteomics

Pharmaceutical products for the treatment of cancer

Providing medical information in the fields of cancer, immune disorders, pharmaceuticals, and proteomics; Providing a web site featuring medical information; Providing a website featuring information in the fields of cancer, immune disorders, pharmaceuticals, and proteomics
vividion therapeutics

General Information


Serial Number98853803
Word MarkVIVIDION THERAPEUTICS
Filing DateThursday, November 14, 2024
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateThursday, November 14, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesProviding a website featuring blogs and non-downloadable publications in the nature of articles in the fields of cancer, immune disorders, pharmaceuticals, and proteomics; Providing a website featuring non-downloadable publications in the nature of articles in the fields of cancer, immune disorders, pharmaceuticals, and proteomics
Goods and ServicesPharmaceutical products for the treatment of cancer
NOT AVAILABLE"THERAPEUTICS"
Goods and ServicesProviding medical information in the fields of cancer, immune disorders, pharmaceuticals, and proteomics; Providing a web site featuring medical information; Providing a website featuring information in the fields of cancer, immune disorders, pharmaceuticals, and proteomics

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, November 14, 2024
Primary Code005
First Use Anywhere DateFriday, June 30, 2023
First Use In Commerce DateFriday, June 30, 2023

International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateThursday, November 14, 2024
Primary Code041
First Use Anywhere DateWednesday, February 28, 2018
First Use In Commerce DateWednesday, February 28, 2018

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, November 14, 2024
Primary Code042
First Use Anywhere DateWednesday, February 28, 2018
First Use In Commerce DateWednesday, February 28, 2018

Trademark Owner History


Party NameVividion Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events


Event DateEvent Description
Thursday, November 14, 2024NEW APPLICATION ENTERED